NCT03441217View on ClinicalTrials.gov

Hyoscine Butylbromide Effect on Duration of Labor

NACompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

July 12, 2019

Primary Completion Date

August 30, 2019

Study Completion Date

November 30, 2019

Conditions
Labor
Interventions
DRUG

Hyoscine Butylbromide 20Mg/1mL Injection

Nulliparous women with gestations at term receive 20 mg of Hyoscine butylbromide upon arrival in the Labor and Delivery Unit (4-5 cms).

DRUG

Saline Solution

Nulliparous women with gestations at term receive 20 mg of saline solution upon arrival in the Labor and Delivery Unit (4-5 cms).

Trial Locations (1)

Unknown

Saint Thomas Maternity Hospital, Panama City

All Listed Sponsors
collaborator

Sistema Nacional de Investigadores de Panamá

UNKNOWN

lead

Saint Thomas Hospital, Panama

OTHER

NCT03441217 - Hyoscine Butylbromide Effect on Duration of Labor | Biotech Hunter | Biotech Hunter